Better Therapeutics (BTTX) Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Over a lifetime horizon AspyreRx plus standard of care was estimated to be superior to SoC alone providing more life years and improvements in quality of life at a lower cost
Study suggests that.